tiprankstipranks
Calidi Biotherapeutics, Inc. (CLDI)
:CLDI
US Market

Calidi Biotherapeutics (CLDI) Income Statement

Compare
212 Followers

Calidi Biotherapeutics Income Statement

Last quarter (Q1 2024), Calidi Biotherapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Calidi Biotherapeutics's net income was $-7.22M. See Calidi Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 45.00K$ 449.00K$ 0.00
Gross Profit
$ -1.26M$ -229.00K$ 355.00K$ 0.00
Operating Expenses
$ 28.99M$ 22.90M$ 1.78M$ 6.77M
Depreciation and Amortization
$ 1.26M$ 260.00K$ 153.00K$ 117.00K
EBITDA
$ -27.58M$ -25.00M$ -9.45M$ -6.65M
Operating Income
$ -28.99M$ -23.13M$ -1.78M$ -6.77M
Other Income/Expenses
$ -208.00K$ -2.29M$ -440.00K$ -1.16M
Pretax Income
$ -29.20M$ -25.42M$ 3.39M$ -7.93M
Net Income
$ -29.22M$ -25.43M$ 3.39M$ -7.94M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -1.73$ -29.90$ 1.18$ -0.22
Diluted EPS
$ -17.30$ -29.90$ 1.18$ -0.22
Weighted Average Shares Outstanding
16.89M 850.50K 2.88M 35.91M
Weighted Average Shares Outstanding (Diluted)
1.69M 850.50K 2.88M 35.91M
Currency in USD

Calidi Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis